100 related articles for article (PubMed ID: 2431799)
1. Iodo- and bromodeoxyuridine are excised at different rates from DNA of mouse tongue keratinocytes in vitro.
Hume WJ; Saffhill R
Chem Biol Interact; 1986 Nov; 60(2):227-32. PubMed ID: 2431799
[TBL] [Abstract][Full Text] [Related]
2. The Fingerprint of Anti-Bromodeoxyuridine Antibodies and Its Use for the Assessment of Their Affinity to 5-Bromo-2'-Deoxyuridine in Cellular DNA under Various Conditions.
Ligasová A; Liboska R; Rosenberg I; Koberna K
PLoS One; 2015; 10(7):e0132393. PubMed ID: 26161977
[TBL] [Abstract][Full Text] [Related]
3. Low doses of bromo- and iododeoxyuridine produce near-saturation labeling of adult proliferative populations in the dentate gyrus.
Burns KA; Kuan CY
Eur J Neurosci; 2005 Feb; 21(3):803-7. PubMed ID: 15733099
[TBL] [Abstract][Full Text] [Related]
4. Incorporation of 5-iodo-2'-deoxyuridine and 5-bromo-2'-deoxyuridine into rodent DNA as determined by neutron activation analysis.
Kitchin KT; Brown JL
Anal Biochem; 1995 Aug; 229(2):180-7. PubMed ID: 7485970
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of 5-lododeoxyuridine into the DNA of mouse embryos: its relation to embryotoxicity.
Skalko RG; Packard DS; Caniano DA; Sax RD
Teratology; 1975 Oct; 12(2):157-64. PubMed ID: 1198326
[TBL] [Abstract][Full Text] [Related]
6. [A study on tongue cancer cell labeling using bromodeoxyuridine (BrdU) incorporation in vitro].
Li X; Zhao Q; He R; Zhou X; Chen W
Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Oct; 19(5):278-80. PubMed ID: 12539478
[TBL] [Abstract][Full Text] [Related]
7. The degradation of 5-iododeoxyuridine and 5-bromodeoxyuridine by serum from different sources and its consequences for the use of the compounds for incorporation into DNA.
Saffhill R; Hume WJ
Chem Biol Interact; 1986 Mar; 57(3):347-55. PubMed ID: 3698122
[TBL] [Abstract][Full Text] [Related]
8. Comparative utilization of bromodeoxyuridine and iododeoxyuridine triphosphates for mammalian DNA replication in vitro.
Gautschi JR; Burkhalter M; Baumann EA
Biochim Biophys Acta; 1978 Mar; 518(1):31-6. PubMed ID: 629978
[TBL] [Abstract][Full Text] [Related]
9. Circadian rhythm of DNA synthesis and mitotic activity in tongue keratinocytes.
García MN; Barbeito CG; Andrini LA; Badrán AF
Cell Biol Int; 2001; 25(2):179-83. PubMed ID: 11237422
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of 5-halogenated deoxyuridines on in vitro keratinization of a transformed rat urinary bladder epithelial cell line.
Kawamura H; Hashimoto Y
Gan; 1981 Apr; 72(2):264-71. PubMed ID: 6169585
[TBL] [Abstract][Full Text] [Related]
11. The degree of ultraviolet light damage to DNA containing iododeoxyuridine or bromodeoxyuridine is dependent on the DNA sequence.
Murray V; Martin RF
Nucleic Acids Res; 1989 Apr; 17(7):2675-91. PubMed ID: 2717406
[TBL] [Abstract][Full Text] [Related]
12. Replication labeling with halogenated thymidine analogs.
Yokochi T; Gilbert DM
Curr Protoc Cell Biol; 2007 Jun; Chapter 22():Unit 22.10. PubMed ID: 18228503
[TBL] [Abstract][Full Text] [Related]
13. Studies of the mechanism of induction of infectious murine leukemia virus from AKR mouse embryo cell lines by 5-iododeoxyuridine and 5-bromodeoxyuridine.
Teich N; Lowy DR; Hartley JW; Rowe WP
Virology; 1973 Jan; 51(1):163-73. PubMed ID: 4346294
[No Abstract] [Full Text] [Related]
14. In situ cell cycle kinetics in bone marrow biopsies following sequential infusions of IUdR/BrdU in patients with hematopoietic malignancies.
Raza A; Yousuf N; Bohkari SA; Sheikh Y; Akhtar S; Chughtai S; Umerani A; Mehdi SA; Miller MA; Masterson M
Leuk Res; 1992; 16(3):299-306. PubMed ID: 1560677
[TBL] [Abstract][Full Text] [Related]
15. Double labeling with iodo- and bromodeoxyuridine for cell kinetics studies.
Shibui S; Hoshino T; Vanderlaan M; Gray JW
J Histochem Cytochem; 1989 Jul; 37(7):1007-11. PubMed ID: 2659659
[TBL] [Abstract][Full Text] [Related]
16. Sister chromatid exchanges induced by light flashes to 5-bromodeoxyuridine- and 5-iododeoxyuridine substituted Chinese hamster chromosomes.
Ikushima T; Wolff S
Exp Cell Res; 1974 Jul; 87(1):15-9. PubMed ID: 4135474
[No Abstract] [Full Text] [Related]
17. The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancer.
Lawrence TS; Davis MA; Maybaum J; Mukhopadhyay SK; Stetson PL; Normolle DP; McKeever PE; Ensminger WD
Cancer Res; 1992 Jul; 52(13):3698-704. PubMed ID: 1617642
[TBL] [Abstract][Full Text] [Related]
18. Improved high-affinity monoclonal antibody to iododeoxyuridine.
Vanderlaan M; Watkins B; Thomas C; Dolbeare F; Stanker L
Cytometry; 1986 Nov; 7(6):499-507. PubMed ID: 3096672
[TBL] [Abstract][Full Text] [Related]
19. Use of the Pyrimidine Analog, 5-Iodo-2'-Deoxyuridine (IdU) with Cell Cycle Markers to establish Cell Cycle Phases in a Mass Cytometry Platform.
Devine RD; Behbehani GK
J Vis Exp; 2021 Oct; (176):. PubMed ID: 34747407
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous immunohistochemical detection of IUdR and BrdU infused intravenously to cancer patients.
Miller MA; Mazewski CM; Yousuf N; Sheikh Y; White LM; Yanik GA; Hyams DM; Lampkin BC; Raza A
J Histochem Cytochem; 1991 Apr; 39(4):407-12. PubMed ID: 2005370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
